Decades late, these set of basic rules for Indian pharma can save lives
Related Posts
Redcliffe Labs is taking on incumbents like Dr Lal PathLabs. But is it biting more than it can chew?
Dheeraj Jain, founder and MD, Redcliffe Labs; image credit: Redcliffe Labs Synopsis Having set itself a target to reach INR5,000 crore in revenue by 2029, Redcliffe Labs is expanding rapidly and spending big on marketing. But scaling up in a services industry like diagnostics isn’t easy. Without sufficient funding, it may not be able to […]
Sarah McMullen, the US FDA exec who soothed Indian pharma’s frayed nerves
Sarah McMullen, USFDA India director Synopsis In the past, many within the Indian pharma industry looked at US FDA audits as motivated and a larger conspiracy against it. But Sarah McMullen, who heads the Indian operations of the US FDA, worked hard to slowly change that, and bring in a culture of quality in the […]
Rajendra Badwe: How Rajendra Badwe is making cancer treatment affordable by repurposing easily available drugs
Dr. Rajendra Achyut Badwe, Director, Tata Memorial Center. Synopsis Badwe, director of Mumbai’s Tata Memorial Centre, has reset the rules to revolutionise treatment standards. His views on disease management and research protocols count not just in India but also at world’s leading institutions. Last September, in one such instance, Badwe and his team of doctors […]